These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16720240)
21. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC). Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386 [TBL] [Abstract][Full Text] [Related]
22. Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer. Jia B; Liu Z; Shi J; Yu Z; Yang Z; Zhao H; He Z; Liu S; Wang F Bioconjug Chem; 2008 Jan; 19(1):201-10. PubMed ID: 18069778 [TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of targeted proapoptotic peptides. Capello A; Krenning EP; Bernard BF; Breeman WA; Erion JL; de Jong M J Nucl Med; 2006 Jan; 47(1):122-9. PubMed ID: 16391196 [TBL] [Abstract][Full Text] [Related]
24. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. Good S; Walter MA; Waser B; Wang X; Müller-Brand J; Béhé MP; Reubi JC; Maecke HR Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1868-77. PubMed ID: 18509636 [TBL] [Abstract][Full Text] [Related]
25. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging. Aloj L; Caracò C; Panico M; Zannetti A; Del Vecchio S; Tesauro D; De Luca S; Arra C; Pedone C; Morelli G; Salvatore M J Nucl Med; 2004 Mar; 45(3):485-94. PubMed ID: 15001692 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P. Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978 [TBL] [Abstract][Full Text] [Related]
29. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
30. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes. Duncan JR; Stephenson MT; Wu HP; Anderson CJ Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843 [TBL] [Abstract][Full Text] [Related]
31. Imaging tumor folate receptors using 111In-DTPA-methotrexate. Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Kim EE; Podoloff DA Cancer Biother Radiopharm; 1998 Jun; 13(3):177-84. PubMed ID: 10850353 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971 [TBL] [Abstract][Full Text] [Related]
33. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody. van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812 [TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313 [TBL] [Abstract][Full Text] [Related]
35. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept. He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145 [TBL] [Abstract][Full Text] [Related]
36. A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. Sano K; Masuda R; Hisada H; Oishi S; Shimokawa K; Ono M; Fujii N; Saji H; Mukai T Bioorg Med Chem Lett; 2014 Mar; 24(5):1386-8. PubMed ID: 24491461 [TBL] [Abstract][Full Text] [Related]
37. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma. Sand LGL; Buckle T; van Leeuwen FWB; Corver WE; Kruisselbrink AB; Jochemsen AG; Hogendoorn PCW; Szuhai K BMC Cancer; 2017 May; 17(1):383. PubMed ID: 28549419 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4. Demmer O; Dijkgraaf I; Schumacher U; Marinelli L; Cosconati S; Gourni E; Wester HJ; Kessler H J Med Chem; 2011 Nov; 54(21):7648-62. PubMed ID: 21905730 [TBL] [Abstract][Full Text] [Related]
39. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. Ke CY; Mathias CJ; Green MA J Am Chem Soc; 2005 May; 127(20):7421-6. PubMed ID: 15898791 [TBL] [Abstract][Full Text] [Related]